Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers
COVIPACT
1 other identifier
observational
809
1 country
2
Brief Summary
This original study will assess the impact of the coronavirus health crisis on the management of patients undergoing medical treatment for cancer, in particularly on the modification of the hospital organization. It will also provide a record of the progress of patients who will have been treated during the epidemic period and infected by the virus. We will also assess the psychological impact of the pandemic in patients but also in caregivers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2020
CompletedFirst Submitted
Initial submission to the registry
April 16, 2020
CompletedFirst Posted
Study publicly available on registry
April 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedDecember 14, 2020
December 1, 2020
3 months
April 16, 2020
December 11, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
To assess the impact of the COVID-19 pandemic on the modifications of treatments administered in hospital (day units) to patients with cancer or malignant hemopathy
Proportion of patients with modification of the treatments administered
up to 6 months
To assess the impact of the COVID-19 pandemic on the change in the rate of treatment administration in hospital (day units) to patients with cancer or malignant hemopathy
Proportion of patients with change in the rate of treatment administration
up to 6 months
To assess the impact of the COVID-19 pandemic on the number of cures administeredin hospital (day units) to patients with cancer or malignant hemopathy
Proportion of patients with change in the number of cures administered
up to 6 months
To assess the impact of the COVID-19 pandemic on change of modality of administration in hospital (day units) to patients with cancer or malignant hemopathy
Proportion of patients with change of modality of administration (home administration to replace day hospital administration, teleconsultation uses)
up to 6 months
Secondary Outcomes (9)
Evaluate the perceived stress on cancer patients treated in unit day of hospital
up to 12 months
Evaluate the post-traumatic stress on cancer patients treated in unit day of hospital
up to 12 months
Evaluate the sleep disorders on cancer patients treated in unit day of hospital
up to 12 months
Evaluate the quality of life on cancer patients treated in unit day of hospital
up to 12 months
Evaluate the cognitive complaints on cancer patients treated in unit day of hospital
up to 12 months
- +4 more secondary outcomes
Study Arms (2)
Patients
Caregivers
Interventions
delivery of questionnaires on perceived stress, post-traumatic stress, sleep disorders, quality of life, cognitive complaint
Eligibility Criteria
2 populations were recruted in this study : patients with cancer and caregivers
You may qualify if:
- For Patients:
- Adult patient, treated for a solid or hematological tumor
- will be treated ou actually treated by oncological treatment carried out at the hospital in day unit of the participating centers: treatment initiated before or during the pandemic with COVID-19
- For the Caregivers:
- \- Medical oncologist, hematologist, intern, nurse and caregiver in day unit of hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre François Baclesse
Caen, France
Centre Henri Becquerel
Rouen, France
Related Publications (2)
Cherifi F, Gernier F, Jardin F, Lefevre-Arbogast S, Bastien E, Lequesne J, Rigal O, Quilan F, Clarisse B, Grellard JM, Binarelli G, Fernette M, Lange M, Richard D, Morel A, Griffon B, Pepin LF, Leconte A, Faveyrial A, Leheurteur M, Beauplet B, Joly F. Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic. J Geriatr Oncol. 2023 Nov;14(8):101634. doi: 10.1016/j.jgo.2023.101634. Epub 2023 Sep 25.
PMID: 37757587DERIVEDBastien E, Lefevre-Arbogast S, Lequesne J, Gernier F, Cherifi F, Rigal O, Guittet L, Grellard JM, Binarelli G, Lange M, Fernette M, Tron L, Morel A, Richard D, Griffon B, Leconte A, Quilan F, Pepin LF, Jardin F, Leheurteur M, Faveyrial A, Clarisse B, Joly F. Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study. J Natl Compr Canc Netw. 2023 Feb 22;21(3):265-272.e7. doi: 10.6004/jnccn.2023.7085.
PMID: 36812938DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2020
First Posted
April 28, 2020
Study Start
April 15, 2020
Primary Completion
July 15, 2020
Study Completion
May 1, 2021
Last Updated
December 14, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share